Michael J Penkunas
Overview
Explore the profile of Michael J Penkunas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Penkunas M, Ross B, Scott C, Thorson A, Baron L, Kammoun Rebai W, et al.
Inquiry
. 2024 Nov;
61:469580241284916.
PMID: 39548770
This study explores the barriers encountered by participants in applying knowledge gained from a massive open online course (MOOC) on implementation research (IR), particularly among learners in low- and middle-income...
2.
Sodhi R, Penkunas M, Pal A
BMC Infect Dis
. 2023 Jun;
23(1):421.
PMID: 37344775
Background: The private sector is an important yet underregulated component of the TB treatment infrastructure in India. The Joint Effort for Elimination of Tuberculosis (Project JEET) aims to link private...
3.
Ross B, Penkunas M, Maher D, Certain E, Launois P
BMJ Open
. 2022 May;
12(5):e054719.
PMID: 35504633
Introduction: An implementation research (IR) massive open online course (MOOC) was developed by the Special Programme for Research and Training in Tropical Diseases, to address the scarcity of training in...
4.
Penkunas M, Chong S, Rhule E, Berdou E, Allotey P
Global Health
. 2021 Jun;
17(1):63.
PMID: 34154605
Efficacious health interventions tested through controlled trials often fail to show desired impacts when implemented at scale. These challenges can be particularly pervasive in low- and middle-income settings where health...
5.
Launois P, Maher D, Certain E, Ross B, Penkunas M
Health Res Policy Syst
. 2021 Apr;
19(1):59.
PMID: 33823859
Background: Implementation research (IR) can play a critical role in the delivery of disease control interventions, particularly in low- and middle-income countries (LMICs). The growing demand for IR training has...
6.
Serumondo J, Penkunas M, Niyikora J, Ngwije A, Kiromera A, Musabeyezu E, et al.
BMC Public Health
. 2020 Jun;
20(1):946.
PMID: 32546216
Background: Direct-acting antivirals (DAAs) are increasingly accessible to patients with hepatitis C (HCV) worldwide and are being introduced through national health systems in sub-Saharan Africa. DAAs are highly efficacious when...
7.
Nsanzimana S, Penkunas M, Liu C, Sebuhoro D, Ngwije A, Remera E, et al.
Clin Infect Dis
. 2020 Jun;
73(9):e3300-e3307.
PMID: 32505127
Background: Direct-acting antivirals (DAAs) are becoming accessible in sub-Saharan Africa. This study examined the effectiveness of DAAs in patients treated through the Rwandan national health system and identified factors associated...
8.
Umutesi J, Yingkai Liu C, Penkunas M, Makuza J, Ntihabose C, Umuraza S, et al.
BMJ Open
. 2019 Jul;
9(7):e029743.
PMID: 31272986
Objectives: We analysed data collected during programmatic screening activities conducted in 2017 to describe hepatitis C virus (HCV) seroprevalence in the general population and identify associated factors. Design: We analysed...
9.
Uwimana A, Penkunas M, Nisingizwe M, Warsame M, Umulisa N, Uyizeye D, et al.
Trans R Soc Trop Med Hyg
. 2019 Mar;
113(6):312-319.
PMID: 30892640
Background: Artemisinin-based combination therapies (ACTs) have proven highly effective in reducing malaria morbidity in sub-Saharan Africa. Artemether-lumefantrine (AL) was introduced in 2005 as a first-line ACT for the treatment of...
10.
Musanabaganwa C, Condo J, Penkunas M, Pillai C, Mills E
Nature
. 2019 Jan;
565(7737):25.
PMID: 30602748
No abstract available.